{
  "docId": "019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "docSlug": "61f4be21d1a97a93f2294133e3bf0c0f",
  "documentTitle": "Bausch Health Companies | Investor Conference Presentation Deck | 10 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 6,
  "pageCount": 10,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_messages",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide outlines the clinical development strategy for a specific drug formulation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-ca7e-71d0-9b6d-c6cccc832e2e/6",
  "deckHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "deckJsonHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e.json",
  "deckAnchorHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.62
      },
      "kind": "list",
      "text": "Phase 3 start 2H21; 1,000 patients/200 sites; 72-week treatment; Primary endpoint: time to first HE; NDA submission 2026.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0be7f269-282e-4be3-9c85-8a1d6ba07fd6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "RED-C Program - Reduction of Early Decompensation in Cirrhosis; \"Upstream\" approach to prevent first HE occurrence; Proof of concept in Phase 2; FDA agreement on Phase 3 design.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "803ee46a-ef57-4031-b0eb-8dd581dab588",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.1,
        "x": 0.05,
        "y": 0.58
      },
      "kind": "title",
      "text": "Timeline",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1da51b90-be5f-470c-a44f-1d34ff9b9262",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "Rifaximin Solid Soluble Dispersion (SSD) in a Tablet",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "446afb08-2611-473e-a3e1-ad40b3cc5e3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.2,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "RED-C Program",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "906011b8-ceca-4e9e-960a-d030d2bbd506",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "6c121b7d-e59c-407f-a5d3-b144ead24979",
      "evidence": "list/bullet: RED-C Program - Reduction of Early Decompensation in Cirrhosis; \"Upstream\" approach to prevent first HE occurrence; Proof of concept in Phase 2; FDA agreement on Phase 3 design.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "26a0baae-0573-4787-a96e-cf35b4858a66",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "Amiselimod Capsules, Rifaximin Solid Soluble Dispersion (SSD) in a Tablet",
      "position": 1,
      "confidence": 0.6,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}